UFP Technologies, Inc. (UFPT) Compounding Analysis

UFP Technologies, Inc.(UFPT)

Medical - Devices · Newburyport, MA

$301.36-5.97 (-1.94%)

Delayed quote: Oct 6, 2026, 3:05 PM EDT

About UFP Technologies, Inc.

UFP Technologies, Inc. specializes in the engineering and custom fabrication of components, subassemblies, finished products, and packaging, primarily utilizing advanced foams, films, and plastics. A significant portion of its business is dedicated to the medical sector, where its single-use and single-patient devices and parts are integral to a broad spectrum of applications, including general medical devices, disposable wound care, infection control, minimally invasive surgical tools, wearable technologies, orthopedic soft goods, and protective packaging for orthopedic implants. Beyond healthcare, the company extends its expertise to the automotive, aerospace and defense, consumer, electronics, and industrial markets. Here, its engineered products and components are incorporated into diverse items such as military uniform and gear, automotive interior trim, athletic padding, sustainable protective packaging, air filtration systems, abrasive nail files, and custom protective cases and inserts. UFP Technologies markets and distributes its offerings across the United States, predominantly through a direct sales force supported by independent manufacturer representatives. The company, established in 1963, is headquartered in Newburyport, Massachusetts.

Newburyport, MA

4,846 employees

www.ufpt.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Mitchell C. Rock

View full financials

Across metrics · 10Y

UFPT reported stats per metric over 10Y: annual CAGR, median quarterly year-over-year growth, YoY standard deviation, quarters at or above 20%, and negative quarters.
Metric	10Y CAGR	Median YoY	YoY σ	Qtrs ≥ 20%	Neg. qtrs
RevenueRevenue	15.8%	9.1%	24.2pp	13 of 40	6
EPSEPS	23.6%	27.7%	45.3pp	23 of 40	9
Op cash flowOperating cash flow	21.5%	1.7%	61.6pp	14 of 40	17
EBITDAEBITDA	21.5%	16.2%	39.4pp	19 of 40	12
FCFFree cash flow	—	-13.3%	69.2pp	11 of 40	19

Reported figures over 10Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.